Related references
Note: Only part of the references are listed.Engineered Anti-GPC3 Immunotoxin, HN3-ABD-T20, Produces Regression in Mouse Liver Cancer Xenografts Through Prolonged Serum Retention
Bryan D. Fleming et al.
HEPATOLOGY (2020)
PiggyBac-engineered T cells expressing a glypican-3-specific chimeric antigen receptor show potent activities against hepatocellular carcinoma
Pei Wang et al.
IMMUNOBIOLOGY (2020)
PIK3CA variants selectively initiate brain hyperactivity during gliomagenesis
Kwanha Yu et al.
NATURE (2020)
Downregulation of glypican-4 facilitates breast cancer progression by inducing cell migration and proliferation
Javaria Munir et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Anti-glypican-1 antibody-drug conjugate is a potential therapy against pancreatic cancer
Takahiko Nishigaki et al.
BRITISH JOURNAL OF CANCER (2020)
Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials
Donghua Shi et al.
CLINICAL CANCER RESEARCH (2020)
GPC1 specific CAR-T cells eradicate established solid tumor without adverse effects and synergize with anti-PD-1 Ab
Daiki Kato et al.
ELIFE (2020)
Glypican-1 Promotes Tumorigenesis by Regulating the PTEN/Akt/-Catenin Signaling Pathway in Esophageal Squamous Cell Carcinoma
Jing Li et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
A Frizzled-Like Cysteine-Rich Domain in Glypican-3 Mediates Wnt Binding and Regulates Hepatocellular Carcinoma Tumor Growth in Mice
Na Li et al.
HEPATOLOGY (2019)
MicroRNA-301b promotes the proliferation and invasion of glioma cells through enhancing activation of Wnt/β-catenin signaling via targeting Glypican-5
Xin Hong et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma
Yuanyuan Li et al.
PLOS ONE (2019)
The Glypican-4 Gene Polymorphism rs1048369 and Susceptibility to Epstein-Barr Virus-Positive and -Negative Nasopharyngeal Carcinoma in Northern China
Shuzhen Liu et al.
ONCOLOGY RESEARCH AND TREATMENT (2019)
CD36 inhibits β-catenin/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis
Yuan Fang et al.
NATURE COMMUNICATIONS (2019)
Glypican-3-Specific Antibody Drug Conjugates Targeting Hepatocellular Carcinoma
Ying Fu et al.
HEPATOLOGY (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Anti-glypican-1 antibody-drug conjugate exhibits potent preclinical antitumor activity against glypican-1 positive uterine cervical cancer
Satoko Matsuzaki et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Overexpression of Glypican 5 (GPC5) Inhibits Prostate Cancer Cell Proliferation and Invasion via Suppressing Sp1-Mediated EMT and Activation of Wnt/β-Catenin Signaling
Yu Sun et al.
ONCOLOGY RESEARCH (2018)
Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors
Nobuhiro Tsuchiya et al.
ONCOIMMUNOLOGY (2018)
Glypican 3 Overexpression across a Broad Spectrum of Tumor Types Discovered with Functional Genomic mRNA Profiling of a Large Cancer Database
Kirsten L. Moek et al.
AMERICAN JOURNAL OF PATHOLOGY (2018)
High expression of microRNA-4295 contributes to cell proliferation and invasion of pancreatic ductal adenocarcinoma by the down-regulation of Glypican-5
Qinggong Yuan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Targeting glypican-4 overcomes 5-FU resistance and attenuates stem cell-like properties via suppression of Wnt/β-catenin pathway in pancreatic cancer cells
Junyu Cao et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Prognostic significance of glypican-3 expression in hepatocellular carcinoma A meta-analysis
Hong Liu et al.
MEDICINE (2018)
Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma An updated meta-analysis
Jian Zhang et al.
MEDICINE (2018)
Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma
Min Yu et al.
MOLECULAR THERAPY (2018)
Adnectin-drug conjugates for Glypican-3-specific delivery of a cytotoxic payload to tumors
Dasa Lipovsek et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2018)
Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden
Adam E. Frampton et al.
Oncotarget (2018)
R-spondins can potentiate WNT signaling without LGRs
Andres M. Lebensohn et al.
ELIFE (2018)
Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1-CH3 fusion protein
Zeyan Pan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Tumor Antigen Escape from CAR T-cell Therapy
Robbie G. Majzner et al.
CANCER DISCOVERY (2018)
Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression
Arvindhan Nagarajan et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma
Xingliang Guo et al.
FRONTIERS IN PHARMACOLOGY (2018)
Construction of an immunotoxin, HN3-mPE24, targeting glypican-3 for liver cancer therapy
Chunguang Wang et al.
ONCOTARGET (2017)
Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity
Wenpeng Li et al.
HUMAN GENE THERAPY (2017)
A mouse model of MYCN-driven retinoblastoma reveals MYCN-independent tumor reemergence
Nan Wu et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Hypoxia-induced HIF1α targets in melanocytes reveal a molecular profile associated with poor melanoma prognosis
Stacie K. Loftus et al.
PIGMENT CELL & MELANOMA RESEARCH (2017)
Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastoma
Nan Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
An anti-glypican 3/CD3 bispecific T cell-redirecting antibody for treatment of solid tumors
Takahiro Ishiguro et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
α3 Chains of type V collagen regulate breast tumour growth via glypican-1
Guorui Huang et al.
NATURE COMMUNICATIONS (2017)
Treatment of hepatocellular carcinoma with a GPC3-targeted bispecific T cell engager
Yanyu Bi et al.
ONCOTARGET (2017)
EVI1 modulates oncogenic role of GPC1 in pancreatic carcinogenesis
Mariko Tanaka et al.
ONCOTARGET (2017)
Glypican-1 targeted antibody-based therapy induces preclinical antitumor activity against esophageal squamous cell carcinoma
Emi Harada et al.
ONCOTARGET (2017)
High Expression of Glypican-1 Predicts Dissemination and Poor Prognosis in Glioblastomas
Taiichi Saito et al.
WORLD NEUROSURGERY (2017)
Elevated glypican-1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma
Haizhen Lu et al.
CANCER MEDICINE (2017)
Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma
Kristopher R. Bosse et al.
CANCER CELL (2017)
Advances and challenges in targeting FGFR signalling in cancer
Irina S. Babina et al.
NATURE REVIEWS CANCER (2017)
A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer
Xianyin Lai et al.
CANCER LETTERS (2017)
Prognostic significance of GPC5 expression in patients with prostate cancer
Changwen Zhang et al.
TUMOR BIOLOGY (2016)
Identification of glypican-3-derived long peptides activating both CD8+ and CD4+ T cells; prolonged overall survival in cancer patients with Th cell response
Mohammad A. Sayem et al.
ONCOIMMUNOLOGY (2016)
Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma
Hisashi Hara et al.
BRITISH JOURNAL OF CANCER (2016)
GPC5, a novel epigenetically silenced tumor suppressor, inhibits tumor growth by suppressing Wnt/β-catenin signaling in lung adenocarcinoma
S. Yuan et al.
ONCOGENE (2016)
Glypican-4 gene polymorphism (rs1048369) and susceptibility to Epstein-Barr virus-associated and -negative gastric carcinoma
Danrui Zhao et al.
VIRUS RESEARCH (2016)
Glypican-5 suppresses Epithelial-Mesenchymal Transition of the lung adenocarcinoma by competitively binding to Wnt3a
Siwei Wang et al.
ONCOTARGET (2016)
Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma
Ahmed Omar Kaseb et al.
ONCOTARGET (2016)
Epitope mapping by a Wnt-blocking antibody: evidence of the Wnt binding domain in heparan sulfate
Wei Gao et al.
SCIENTIFIC REPORTS (2016)
Comparative genetic screens in human cells reveal new regulatory mechanisms in WNT signaling
Andres M. Lebensohn et al.
ELIFE (2016)
Glypican-1 as a Biomarker for Prostate Cancer: Isolation and Characterization
Quach Truong et al.
JOURNAL OF CANCER (2016)
Immunoglobulin Transporting Receptors Are Potential Targets for the Immunity Enhancement and Generation of Mammary Gland Bioreactor
Xuemei Jiang et al.
FRONTIERS IN IMMUNOLOGY (2016)
Efficacy of glypican-3-derived peptide vaccine therapy on the survival of patients with refractory ovarian clear cell carcinoma
Shiro Suzuki et al.
OncoImmunology (2016)
Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients
Yu Sawada et al.
ONCOIMMUNOLOGY (2016)
Humanization of high-affinity antibodies targeting glypican-3 in hepatocellular carcinoma
Yi-Fan Zhang et al.
SCIENTIFIC REPORTS (2016)
miR-709 up-regulated in hepatocellular carcinoma, promotes proliferation and invasion by targeting GPC5
Tonggang Liu et al.
CELL PROLIFERATION (2015)
Expression of Glypican 3 in low and high grade urothelial carcinomas
Oguz Aydin et al.
DIAGNOSTIC PATHOLOGY (2015)
T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in Mice
Christina Dargel et al.
GASTROENTEROLOGY (2015)
Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk
Ernest K. Amankwah et al.
GENETIC EPIDEMIOLOGY (2015)
Processing by Convertases Is Required for Glypican-3-induced Inhibition of Hedgehog Signaling
Mariana Capurro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Glypican-3 Targeted Human Heavy Chain Antibody as a Drug Carrier for Hepatocellular Carcinoma Therapy
Hirofumi Hanaoka et al.
MOLECULAR PHARMACEUTICS (2015)
Photoimmunotherapy of hepatocellular carcinoma-targeting Glypican-3 combined with nanosized albumin-bound paclitaxel
Hirofumi Hanaoka et al.
NANOMEDICINE (2015)
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
Sonia A. Melo et al.
NATURE (2015)
Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signalling and protein synthesis
Wei Gao et al.
NATURE COMMUNICATIONS (2015)
Overexpression of GPC6 and TMEM132D in Early Stage Ovarian Cancer Correlates with CD8+T-Lymphocyte Infiltration and Increased Patient Survival
Athanasios Karapetsas et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Human Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells
Wei Gao et al.
PLOS ONE (2015)
Glypican 3 overexpression in primary and metastatic Wilms tumors
Maria Tretiakova et al.
VIRCHOWS ARCHIV (2015)
GPC3 reduces cell proliferation in renal carcinoma cell lines
Marina Curado Valsechi et al.
BMC CANCER (2014)
Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma
Huiping Gao et al.
CLINICAL CANCER RESEARCH (2014)
Inactivation of Wnt Signaling by a Human Antibody That Recognizes the Heparan Sulfate Chains of Glypican-3 for Liver Cancer Therapy
Wei Gao et al.
HEPATOLOGY (2014)
Autoregulation of glypican-1 by intronic microRNA-149 fine tunes the angiogenic response to FGF2 in human endothelial cells
Aranzazu Chamorro-Jorganes et al.
JOURNAL OF CELL SCIENCE (2014)
Glypican-3 binds to Frizzled and plays a direct role in the stimulation of canonical Wnt signaling
Mariana Capurro et al.
JOURNAL OF CELL SCIENCE (2014)
The role of glypicans in Hedgehog signaling
Jorge Filmus et al.
MATRIX BIOLOGY (2014)
Heparan sulfate signaling in cancer
Erik H. Knelson et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
Extracellular Matrix Proteins Expression Profiling in Chemoresistant Variants of the A2780 Ovarian Cancer Cell Line
Radoslaw Januchowski et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Randomized phase II trial of intravenous R05137382/GC33 at 1600 mg every other week and placebo in previously treated patients with unresectable advanced hepatocellular carcinoma (HCC; NCT01507168).
Chia-Jul Yen et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
GPC-1 may serve as a predictor of perineural invasion and a prognosticator of survival in pancreatic cancer
Lian Duan et al.
ASIAN JOURNAL OF SURGERY (2013)
Glypican-5 is a novel metastasis suppressor gene in non-small cell lung cancer
Xin Yang et al.
CANCER LETTERS (2013)
Characterization of genetic lesions in rhabdomyosarcoma using a high-density single nucleotide polymorphism array
Riki Nishimura et al.
CANCER SCIENCE (2013)
First-in-Man Phase I Study of GC33, a Novel Recombinant Humanized Antibody Against Glypican-3, in Patients with Advanced Hepatocellular Carcinoma
Andrew X. Zhu et al.
CLINICAL CANCER RESEARCH (2013)
A functional screening identifies five micrornas controlling glypican-3: role of mir-1271 down-regulation in hepatocellular carcinoma
Marion Maurel et al.
HEPATOLOGY (2013)
Immunohistochemical Expression of Glypican-3 in Pediatric Tumors: An Analysis of 414 Cases
Elaine S. Chan et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2013)
Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma
Mingqian Feng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The overexpression of glypican-5 promotes cancer cell migration and is associated with shorter overall survival in non-small cell lung cancer
Yan Li et al.
ONCOLOGY LETTERS (2013)
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
Marcel Kool et al.
ACTA NEUROPATHOLOGICA (2012)
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells
James N. Kochenderfer et al.
BLOOD (2012)
Phase I Trial of a Glypican-3-Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
Yu Sawada et al.
CLINICAL CANCER RESEARCH (2012)
Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma
Li Li et al.
HEPATOLOGY (2012)
LRP1 mediates Hedgehog-induced endocytosis of the GPC3-Hedgehog complex
Mariana I. Capurro et al.
JOURNAL OF CELL SCIENCE (2012)
Localization of glypican-4 in different membrane microdomains is involved in the regulation of Wnt signaling
Hiroshi Sakane et al.
JOURNAL OF CELL SCIENCE (2012)
Deregulation of Hippo kinase signalling in Human hepatic malignancies
Hua Li et al.
LIVER INTERNATIONAL (2012)
High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening
Yen Phung et al.
MABS (2012)
Molecular basis of differential target regulation by miR-96 and miR-182: the Glypican-3 as a model
Sandra Jalvy-Delvaille et al.
NUCLEIC ACIDS RESEARCH (2012)
A KrasG12D-driven genetic mouse model of pancreatic cancer requires glypican-1 for efficient proliferation and angiogenesis
C. A. Whipple et al.
ONCOGENE (2012)
Identification of cell surface proteins as potential immunotherapy targets in 12 pediatric cancers
Rimas J. Orentas et al.
FRONTIERS IN ONCOLOGY (2012)
NFAT promotes carcinoma invasive migration through glypican-6
Gary K. Yiu et al.
BIOCHEMICAL JOURNAL (2011)
Advances in Liver Cancer Antibody Therapies A Focus on Glypican-3 and Mesothelin
Mitchell Ho
BIODRUGS (2011)
HLA-A2-restricted glypican-3 peptide-specific CTL clones induced by peptide vaccine show high avidity and antigen-specific killing activity against tumor cells
Toshiaki Yoshikawa et al.
CANCER SCIENCE (2011)
Fine-tuning of cell signaling by glypicans
A. Fico et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Glypican-3: A new target for cancer immunotherapy
Mitchell Ho et al.
EUROPEAN JOURNAL OF CANCER (2011)
Glypican-5 stimulates rhabdomyosarcoma cell proliferation by activating Hedgehog signaling
Fuchuan Li et al.
JOURNAL OF CELL BIOLOGY (2011)
Glypican-3 is expressed in rhabdomyosarcomas but not adult spindle cell and pleomorphic sarcomas
Khin Thway et al.
JOURNAL OF CLINICAL PATHOLOGY (2011)
A lung cancer gene GPC5 could also be crucial in breast cancer
Changwen Zhang et al.
MOLECULAR GENETICS AND METABOLISM (2011)
Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers
Akash Kumar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Heparan Sulfate Proteoglycans
Stephane Sarrazin et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
Suppression of Glypican 3 Inhibits Growth of Hepatocellular Carcinoma Cells through Up-Regulation of TGF-β2
Chris K. Sun et al.
NEOPLASIA (2011)
Novel Duplication in Glypican-4 as an Apparent Cause of Simpson-Golabi-Behmel Syndrome
John Waterson et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2010)
Allelic imbalance at 13q31 is associated with reduced GPC6 in Chinese with sporadic retinoblastoma
Charles S. L. Lau et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2010)
Genetic variants and risk of lung cancer in never smokers: a genome-wide association study
Yafei Li et al.
LANCET ONCOLOGY (2010)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells
Kiyotaka Nakano et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma
Hirofumi Shirakawa et al.
CANCER SCIENCE (2009)
Human Hepatocellular Carcinoma Tumor-derived Endothelial Cells Manifest Increased Angiogenesis Capability and Drug Resistance Compared with Normal Endothelial Cells
Yu-Quan Xiong et al.
CLINICAL CANCER RESEARCH (2009)
Overgrowth of a mouse model of Simpson-Golabi-Behmel syndrome is partly mediated by Indian Hedgehog
Mariana I. Capurro et al.
EMBO REPORTS (2009)
Glypican-3 expression in clear cell adenocarcinoma of the ovary
Daichi Maeda et al.
MODERN PATHOLOGY (2009)
The expression profile of glypican-3 and its relation to macrophage population in human hepatocellular carcinoma
Hirotake Takai et al.
LIVER INTERNATIONAL (2009)
CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior
Roy L. Silverstein et al.
SCIENCE SIGNALING (2009)
Expression of glypican 3 in ovarian and extragonadal germ cell tumors
Debra L. Zynger et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: A tissue microarray analysis of 4,387 tissue samples
Daniel Baumhoer et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary
Ghada E. Esheba et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma
A. Bengochea et al.
BRITISH JOURNAL OF CANCER (2008)
Anti-Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer
Takahiro Ishiguro et al.
CANCER RESEARCH (2008)
The role of glypican-3 in the regulation of body size and cancer
Jorge Filmus et al.
CELL CYCLE (2008)
Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding
Mariana I. Capurro et al.
DEVELOPMENTAL CELL (2008)
Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases
Debra L. Zynger et al.
HUMAN PATHOLOGY (2008)
Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells
Takurna Aikawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinoma
Sarit Aviel-Ronen et al.
MODERN PATHOLOGY (2008)
Hedgehog signal pathway is activated in ovarian carcinomas, correlating with cell proliferation: It's inhibition leads to growth suppression and apoptosis
Xiaojun Chen et al.
CANCER SCIENCE (2007)
Role for amplification and expression of Glypican-5 in rhabdomyosarcoma
Daniel Williamson et al.
CANCER RESEARCH (2007)
Immunohistochemical study of glypican 3 in thyroid cancer
Kanako Yamanaka et al.
ONCOLOGY (2007)
A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis
Josep M. Llovet et al.
GASTROENTEROLOGY (2006)
Glypican 3: A novel marker in testicular germ cell tumors
Debra L. Zynger et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules
Louis Libbrecht et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Glypican-1 is frequently overexpressed in human gliomas and enhances FGF-2 signaling in glioma cells
Gui Su et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
VEGF receptor signalling - in control of vascular function
AK Olsson et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Identification of HLA-A2-or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma
H Komori et al.
CLINICAL CANCER RESEARCH (2006)
The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma
N Yamauchi et al.
MODERN PATHOLOGY (2005)
Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling
MI Capurro et al.
CANCER RESEARCH (2005)
Wnt/β-catenin signaling acts upstream of N-myc, BMP4, and FGF signaling to regulate proximal-distal patterning in the lung
WG Shu et al.
DEVELOPMENTAL BIOLOGY (2005)
Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer
M Kubo et al.
CANCER RESEARCH (2004)
Glypican-1 antisense transfection modulates TGF-β-dependent signaling in Colo-357 pancreatic cancer cells
JS Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Mouse homologue of a novel human oncofetal antigen, glypican-3, evokes T-cell-mediated tumor rejection without autoimmune reactions in mice
T Nakatsura et al.
CLINICAL CANCER RESEARCH (2004)
Identification of glypican-3 as a novel tumor marker for melanoma
T Nakatsura et al.
CLINICAL CANCER RESEARCH (2004)
Glypican-3: A novel serum and histochemical marker for hepatocellular carcinoma
M Capurro et al.
GASTROENTEROLOGY (2003)
Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 signaling in brain endothelial cells
DH Qiao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling
Y Midorikawa et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor
H Kim et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2003)
Somatic glypican 3 (GPC3) mutations in Wilms' tumour
GRM White et al.
BRITISH JOURNAL OF CANCER (2002)
Glypican-3 expression is silenced in human breast cancer
YY Xiang et al.
ONCOGENE (2001)
Glypican-3 expression in Wilms tumor and hepatoblastoma
JA Toretsky et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2001)
Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders
ZW Zhu et al.
GUT (2001)
Glypicans in growth control and cancer
J Filmus
GLYCOBIOLOGY (2001)
Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma
SS Murthy et al.
ONCOGENE (2000)
Share Paper
